This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004;364(9432):393-5.

doi: 10.1016/S0140-6736(04)16779-2.

Anthrax and bioterrorism: are we prepared?

Jeremy Mogridge¹

Affiliations

PMID: 15288719
DOI: 10.1016/S0140-6736(04)16779-2

Comment

Anthrax and bioterrorism: are we prepared?

Jeremy Mogridge. Lancet. 2004.

. 2004;364(9432):393-5.

doi: 10.1016/S0140-6736(04)16779-2.

Author

Jeremy Mogridge¹

Affiliation

¹ Laboratory Medicine and Pathobiology, Medical Sciences Building, University of Toronto, Toronto, Ontario M5S 1A8, Canada. jeremy.mogridge@utoronto.ca

PMID: 15288719
DOI: 10.1016/S0140-6736(04)16779-2

No abstract available

PubMed Disclaimer

Comment in

Clinical predictors of bioterrorism-related inhalational anthrax.
Tepper M, Whitehead J. Tepper M, et al. Lancet. 2005 Jan 15-21;365(9455):214; author reply 215. doi: 10.1016/S0140-6736(05)17736-8. Lancet. 2005. PMID: 15652600 No abstract available.

Comment on

Clinical predictors of bioterrorism-related inhalational anthrax.
Kyriacou DN, Stein AC, Yarnold PR, Courtney DM, Nelson RR, Noskin GA, Handler JA, Frerichs RR. Kyriacou DN, et al. Lancet. 2004 Jul 31-Aug 6;364(9432):449-52. doi: 10.1016/S0140-6736(04)16769-X. Lancet. 2004. PMID: 15288744

Similar articles

Clinical predictors of bioterrorism-related inhalational anthrax.
Kyriacou DN, Stein AC, Yarnold PR, Courtney DM, Nelson RR, Noskin GA, Handler JA, Frerichs RR. Kyriacou DN, et al. Lancet. 2004 Jul 31-Aug 6;364(9432):449-52. doi: 10.1016/S0140-6736(04)16769-X. Lancet. 2004. PMID: 15288744
Zoonosis update. Anthrax.
Shadomy SV, Smith TL. Shadomy SV, et al. J Am Vet Med Assoc. 2008 Jul 1;233(1):63-72. doi: 10.2460/javma.233.1.63. J Am Vet Med Assoc. 2008. PMID: 18593313 Review. No abstract available.
More on anthrax exposure case report.
McFee RB, Howell JT. McFee RB, et al. J Am Osteopath Assoc. 2002 Jul;102(7):362-3; author reply 363-4. J Am Osteopath Assoc. 2002. PMID: 12138949 No abstract available.
Clinical predictors of bioterrorism-related inhalational anthrax.
Gair R. Gair R. Lancet. 2005 Jan 15-21;365(9455):214-5; author reply 215. doi: 10.1016/S0140-6736(05)17737-X. Lancet. 2005. PMID: 15652599 No abstract available.
Recognition and management of anthrax--an update.
Swartz MN. Swartz MN. N Engl J Med. 2001 Nov 29;345(22):1621-6. doi: 10.1056/NEJMra012892. Epub 2001 Nov 6. N Engl J Med. 2001. PMID: 11704686 Review. No abstract available.

See all similar articles

Cited by

Anthrax SET protein: a potential virulence determinant that epigenetically represses NF-κB activation in infected macrophages.
Mujtaba S, Winer BY, Jaganathan A, Patel J, Sgobba M, Schuch R, Gupta YK, Haider S, Wang R, Fischetti VA. Mujtaba S, et al. J Biol Chem. 2013 Aug 9;288(32):23458-72. doi: 10.1074/jbc.M113.467696. Epub 2013 May 29. J Biol Chem. 2013. PMID: 23720780 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information